A phase II, non-comparative randomised trial of two treatments involving liposomal amphotericin B and miltefosine for post-kala-azar dermal leishmaniasis in India and Bangladesh.
Sundar S, Pandey K, Mondal D, Madhukar M, Kamal Topno R, Kumar A, Kumar V, Kumar Verma D, Chakravarty J, Chaubey R, Kumari P, Rashid MU, Maruf S, Ghosh P, Raja S, Rode J, den Boer M, Das P, Alvar J, Rijal S, Alves F.
Sundar S, et al. Among authors: kumar v, kumar verma d, kumar a.
PLoS Negl Trop Dis. 2024 Jun 20;18(6):e0012242. doi: 10.1371/journal.pntd.0012242. eCollection 2024 Jun.
PLoS Negl Trop Dis. 2024.
PMID: 38900786
Free PMC article.
Clinical Trial.